INTERNET BASED TESTS FOR CHRONIC PAIN VICTIMS

I have been the Chairman and CEO of an Internet-based Chronic Pain Testing Company for over 2 years.I thought the material below would describe what it is we offer, from the inventor of the technology whom I have worked with for over 15 years.

MY INTERNET BASED TESTS

As you know, I have published 3 books, 33 medical text book chapters, and 58 articles. I found the 40%-67% of chronic pain patients are misdiagnosed. This led to the development of the following questionnaires available over the Internet.

1)      Mensana Clinic Diagnostics, which markets two Internet based questionnaires, which have two purposes a) the Pain Validity Test ($300) predicts with 95% accuracy who will have abnormalities on objective medical testing, and predicts with 85% accuracy who will not have any abnormalities. The test costs $300, and depending on the results, it has application for insurance companies to detect fraud for a fraction of what they now spend ($3,500 to $5,000 or more for fraud investigation), (see www.InternetMedicalEvaluation s.com )and for plaintiff attorneys (see www.MarylandClinicalDiagnostics.com)  to prove that their client is not faking. Since there are two different audiences, with two different agendas, there needed to be two different websites. Since the test just tells the truth, and is not biased, and is based on 7 articles published in the medical literature on 794 patients, it is always admitted in court. It was developed by a team of doctors from Johns Hopkins Hospital, shown below.

•                Donlin Long, MD, Ph.D. former chairman of neurosurgery Johns Hopkins Hospital, founder and Director of the Pain Clinic, Johns Hopkins Hospital, professor of neurosurgery, Johns Hopkins University School of Medicine

•          James Campbell, MD –professor of neurosurgery, Johns Hopkins University School of Medicine, past president, American Pain Society

•          Reginald Davis, MD – former  chief  resident in neurosurgery, Johns Hopkins Hospital, assistant professor of neurosurgery, Johns Hopkins University School of Medicine, chief of neurosurgery, Greater Baltimore Medical Center

•          Nelson Hendler, MD, MS, former assistant professor of neurosurgery-Johns Hopkins University School of Medicine, past president, American Academy of Pain Management

•          John Rybock, MD, assistant professor of neurosurgery Johns Hopkins University School of Medicine, assistant dean for academic affairs, Johns Hopkins University School of Medicine.

2)      The Diagnostic Paradigm and Treatment Algorithm ($800) which generates diagnoses which have a 95% correlation with diagnoses of Johns Hopkins Hospital staff members (published), and then offers a Treatment Algorithm, which tells the doctors what test to order, and treatment to give, so they can get the same results as Mensana Clinic, which had published outcome studies showing results far better than what the insurance companies can obtain. Again, this test is offered via the two B2B websites, mentioned above, and in a scaled down version on a B2C website (www.DiagnoseMyPain.com )  for $49.95. It is available in 8 languages, and reaches 1,000,000,000 Internet users around the world (English, Spanish, Italian, French, Portuguese, German, Russian and Arabic).

These tests can be

A)     sold directly to consumers, without any cost of goods to you, through your MLM company, and

B)      can be used in any clinical setting to enhance accuracy of diagnosis, speed evaluations, and assure proper patient care, regard of how dumb the doctor is. This would work well in your projected clinics.

C)      Be sold to trial attorneys

D)     be sold to insurance or reinsurance companies to save them money. The potential sales here are huge…$10,000,000 per company per year, for a re-insurance company

LECTIN- A NUTRACUTICAL WHICH COATS VIRUSES AND BACTERIA

These products represent a paradigm shift in treating infectious disease. Instead of trying to kill the bacteria, or virus, these products coats the infective, organism, rendering them harmless, and thereby eliminate the development of resistant organisms. This company already has a patient for using their product to treat heliobacter pylori, the causative organism of ulcer, the largest segment of the pharmaceutical market, and has patent pending for treating malaria, cholera, and all sexually transmitted diseases. These last three groups represent the leading cause of death in developing countries. The CEO is full professor at Uni. of Maryland, and headed the Anthrax vaccine project at Ft. Dietrich, the Department of Defense lab for biological warfare, in Maryland (don’t drink the water around there Ron).

MEDICAL TOURISM

One project I have worked on, which took me to the Philippines, representing our joint venture partner, Johns Hopkins Hospital, was to establish medical clinics doing high quality health care, with US trained and certified doctors, under the supervision of Johns Hopkins surgeons, for cardiovascular surgery, joint replacement, back surgery and chronic pain. Hopkins tried to steal the project from us, and the CEO sued Hopkins for $12,000,000 and won. Now, without involvement of the Hospital, he has started the project again, with retired chairmen of various departments from Johns Hopkins, without hospital interference. We almost had a project in Monterey, Mexico, through my introduction of the project to Starwoods, through my friend, who is VP, but then the drug lords started killing tourists and government officials there, and no-one wanted to go to have surgery offshore. We again are re-exploring the Philippines, and China, of all places.